Inhalation CDMO Market Growth Outlook Reveals A CAGR Of 6.6% And A Market Value Of $3.03 Billion By 2030
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Inhalation CDMO Market Value Expansion And Long-Term Growth Outlook
The inhalation CDMO market has experienced robust expansion in recent years. Its value is projected to increase from $2.2 billion in 2025 to $2.35 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.4%. The historic growth is driven by factors such as the growing incidence of asthma and chronic obstructive pulmonary disease (COPD), a rising need for inhalation-based treatments, the emergence of biologics and specialized drug formulations, progress in formulation technologies, and a heightened reliance on outsourcing by pharmaceutical firms.
The inhalation CDMO market is forecast to undergo significant expansion over the next several years, with projections indicating it will reach $3.03 billion by 2030, reflecting a compound annual growth rate of 6.6%. This anticipated increase during the forecast period is driven by several key factors, including the widespread adoption of digital and smart inhalers, advances in personalized medicine and precision therapy, greater financial commitment to inhalation CDMO infrastructure, broader implementation of cutting-edge manufacturing technologies, and a higher frequency of collaborations between biotech firms and CDMOs. Notable trends expected to shape this period involve the development of customized inhalation therapies, novel formulation methods and drug delivery technologies, improvements in regulatory compliance and quality assurance, the growth of contract manufacturing capabilities tailored for small and medium-sized enterprises, and the convergence of smart inhaler technology with digital health monitoring systems.
Download A Free Sample Report For Comprehensive Market Insights:
Inhalation CDMO Market Growth Momentum: Which Factors Are Influencing Demand?
The anticipated growth of the inhalation CDMO market is being driven by the rising incidence of respiratory disorders. These conditions encompass a range of medical issues affecting the respiratory system, including the organs and structures necessary for breathing. Inhalation CDMOs play a key role in developing and manufacturing products for such disorders, leveraging their specialized knowledge in formulating and delivering drugs to the lungs, while providing pharmaceutical companies with the expertise, infrastructure, and resources needed to advance innovative inhalation therapies. For example, in December 2023, the National Library of Medicine, a US-based medical library, reported that the global number of chronic obstructive pulmonary disease (COPD) cases among individuals aged 25 and older is expected to increase by 23% by 2050, reaching nearly 600 million. Consequently, the growing prevalence of respiratory disorders is fueling the expansion of the inhalation CDMO market.
Inhalation CDMO Market Categorization By Product Type And Application
The inhalation cdmo market covered in this report is segmented –
1) By Product: Dry Powder Inhaler (DPIs), Metered Dose Inhaler (MDIs), Nebulizer, Soft Mist Inhaler
2) By Disease Indication: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension, Acute Respiratory Distress Syndrome, Pulmonary Fibrosis
3) By Technology: Manual Inhalers (SMI), Digital Inhalers
4) By End-User: Big Pharmaceutical Companies, Small and Medium-sized Pharmaceutical Companies, Generic Pharmaceutical Companies, Other End-Users
Subsegments:
1) By Dry Powder Inhaler (DPIs): Capsule-Based DPIs, Diskus-Style DPIs, Multi-Dose DPIs, Unit-Dose DPIs
2) By Metered Dose Inhaler (MDIs): Pressurized MDIs (pMDIs), Breath-Actuated MDIs, Soft Mist MDIs
3) By Nebulizer: Jet Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers, Portable Nebulizers
4) By Soft Mist Inhaler: Respimat Inhalers, Other Soft Mist Inhalation Devices
Inhalation CDMO Market Trends Reshaping Industry Growth
Leading firms within the inhalation CDMO sector are increasingly utilizing strategic alliances to deliver specialized capabilities in drug development and delivery. A strategic alliance represents a long-term, cooperative relationship between organizations that collaborates to accomplish mutual objectives. For example, in May 2023, Hovione, a contract development and manufacturing organization based in Portugal, formed a collaboration with H&T Presspart, a UK-based producer of high-precision pharmaceutical metal and plastic components, to advance Presspart’s Sunrise Capsule-based Dry Powder Inhaler system. This collaboration is aimed at creating novel technologies that enable higher drug dosages and enhance the effectiveness of lung drug delivery.
Inhalation CDMO Market Company Landscape And Strategic Competition
Major companies operating in the inhalation cdmo market are Baxter’s BioPharma Solutions, Lonza Group AG, Catalent Inc., Siegfried Holding AG, Recipharm AB, Stevanato Group SpA, CordenPharma, Nemera, Hovione FarmaCiencia SA, Vectura Group Ltd., CARBOGEN AMCIS, Kindeva Drug Delivery Ltd., Frontage Laboratories Inc, Sanner GmbH, H&T Presspart Ltd., Astech Projects Ltd, Cliantha Research, Copley Scientific, Cambrex Corporation, AptarGroup Inc.
Access The Complete Inhalation CDMO Market Report:
Inhalation CDMO Market Largest Region: Which Geography Holds The Highest Market Share?
North America was the largest region in the inhalation contract development and manufacturing organization (CDMO) market in 2025. The regions covered in the inhalation cdmo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
